Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- FWS Restores 5-Year Minimum Age for Exported American Ginseng
The US Fish & Wildlife Service (FWS) has just announced that the export of wild American ginseng (Panax quinquefolius) roots that are at least 5 years old “will not be detrimental to the survival of the species,” and so will be allowed to be exported from states that maintain ginseng programs during the next three harvest seasons (2006–2008).
- FWS Restores 5-Year Minimum Age for Exported American Ginseng
The US Fish & Wildlife Service (FWS) has just announced that the export of wild American ginseng (Panax quinquefolius) roots that are at least 5 years old “will not be detrimental to the survival of the species,” and so will be allowed to be exported from states that maintain ginseng programs during the next three harvest seasons (2006–2008).
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- CRN Applauds Senators On AER Bill Introduction
CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them.
- CRN Applauds Senators On AER Bill Introduction
CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- FDA Reaffirms: Nicotine Not Allowed in Dietary Supplements
FDA has informed a marketer of a product containing nicotine and labeled as a dietary supplement that the product “does not meet the definition of a dietary supplement [and] is an unapproved new drug whose marketing violates the [Federal Food, Drug, and Cosmetic Act].”
- FDA Reaffirms: Nicotine Not Allowed in Dietary Supplements
FDA has informed a marketer of a product containing nicotine and labeled as a dietary supplement that the product “does not meet the definition of a dietary supplement [and] is an unapproved new drug whose marketing violates the [Federal Food, Drug, and Cosmetic Act].”
- Public Comment Sought on Mandatory Folic Acid Fortification
The Australia and New Zealand Food Regulation Ministerial Council asked FSANZ to consider developing a food standard for the mandatory fortification of food with folic acid. A draft standard recommending that folic acid be added to flour used for bread making is now available for public comment.
- Public Comment Sought on Mandatory Folic Acid Fortification
The Australia and New Zealand Food Regulation Ministerial Council asked FSANZ to consider developing a food standard for the mandatory fortification of food with folic acid. A draft standard recommending that folic acid be added to flour used for bread making is now available for public comment.
- SLIMALUMA Achieves Self-Affirmed GRAS Status
Expert panel affirms product's saftety for use in foods.
- SLIMALUMA Achieves Self-Affirmed GRAS Status
Expert panel affirms product's saftety for use in foods.
- SLIMALUMA Achieves Self-Affirmed GRAS Status
Expert panel affirms product's saftety for use in foods.
- SLIMALUMA Achieves Self-Affirmed GRAS Status
Expert panel affirms product's saftety for use in foods.
- POS Pilot Plant Receives Health Canada Site License for Manufacturing Natural Health Products
POS Pilot Plant has received its site license for manufacturing natural health products for sale in Canada.
- POS Pilot Plant Receives Health Canada Site License for Manufacturing Natural Health Products
POS Pilot Plant has received its site license for manufacturing natural health products for sale in Canada.
- POS Pilot Plant Receives Health Canada Site License for Manufacturing Natural Health Products
POS Pilot Plant has received its site license for manufacturing natural health products for sale in Canada.
- FDA Warns Consumers About Dangerous Ingredients in "Dietary Supplements" Promoted for Sexual Enhancement
FDA is warning consumers not to purchase or consume Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx, or 4EVERON, products that are promoted and sold on web sites as "dietary supplements" for treating erectile dysfunction (ED) and enhancing sexual performance, as they are illegal drugs that contain potentially harmful undeclared ingredients.
- FDA Warns Consumers About Dangerous Ingredients in "Dietary Supplements" Promoted for Sexual Enhancement
FDA is warning consumers not to purchase or consume Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx, or 4EVERON, products that are promoted and sold on web sites as "dietary supplements" for treating erectile dysfunction (ED) and enhancing sexual performance, as they are illegal drugs that contain potentially harmful undeclared ingredients.
- UK's MHRA to Require Label Warning on Black Cohosh
The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.”
- UK's MHRA to Require Label Warning on Black Cohosh
The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.”
- UK's MHRA to Require Label Warning on Black Cohosh
The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.”
- UK's MHRA to Require Label Warning on Black Cohosh
The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.”
- UK's MHRA to Require Label Warning on Black Cohosh
The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.”
- UK's MHRA to Require Label Warning on Black Cohosh
The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.”
- ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada
has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada.
- ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada
has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada.
- ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada
has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada.
- ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada
has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada.
- ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada
has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada.
- Open Call for Nominations to the Expert Advisory Committee (EAC) on Natural Health Products
The Natural Health Products Directorate (NHPD) is seeking to fill six positions with the EAC. The closing date for nominations is August 21, 2006.
- Open Call for Nominations to the Expert Advisory Committee (EAC) on Natural Health Products
The Natural Health Products Directorate (NHPD) is seeking to fill six positions with the EAC. The closing date for nominations is August 21, 2006.
- Open Call for Nominations to the Expert Advisory Committee (EAC) on Natural Health Products
The Natural Health Products Directorate (NHPD) is seeking to fill six positions with the EAC. The closing date for nominations is August 21, 2006.
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- Marketers of Seasilver Ordered to Pay Almost $120 Million
The marketers of Seasilver, an alleged phony cure-all, have been ordered to pay almost $120 million for failing to comply with an earlier order requiring them to pay $3 million in consumer redress.
- Marketers of Seasilver Ordered to Pay Almost $120 Million
The marketers of Seasilver, an alleged phony cure-all, have been ordered to pay almost $120 million for failing to comply with an earlier order requiring them to pay $3 million in consumer redress.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Dietary supplements are safe. Senate Bill 3546 makes them even safer.
WASHINGTON, D.C & MINNEAPOLIS, MN, July 4, 2006 – Citizens for Health commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing Senate Bill 3546, the “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that will require manufacturers to notify the FDA of all serious adverse events (AEs) for over-the-counter (OTC) drugs and dietary supplements reported to them.
Joining with other consumer groups and trade associations in supporting this bill, Citizens for Health also thanks the dietary supplement industry for having set a good example over the years by working hard to voluntarily log and submit the small number of serious adverse events (side effects) that may or may not have been definitively associated with the use of dietary supplements, but which have been submitted in good faith regardless.
Not only does the bill show a serious commitment to consumer safety and protection by the dietary supplement industry - it also includes appropriate safeguards so that unjustified burdens are not placed on these responsible companies.
This bill emphasizes how well-regulated the dietary supplement industry actually is and how committed supplement companies already are to safety and to making the existing regulations work more effectively.
Citizens for Health looks forward to the passage of this bill in the Senate and encourages the House of Representatives to take similar steps. The bill was expected to go to the Senate floor for a vote in mid-July.
Citizens for Health is today mobilizing a major grassroots information campaign in support of the joint consumer-trade collaboration endorsing this bill by engaging its 108,000 consumer members.
Citizens for Health invites industry to spread its action campaign letter links to consumers across the United States: Ask your customers to co-sponsor S. 3546 today!
The association also invites industry members to check out information on this bill from the National Nutritional Foods Association (NNFA) the Council for Responsible Nutrition (CRN) and the Consumer Healthcare Products Association (CHPA).
About Citizens for Health
Citizens for Health (www.citizens.org) is a national non-profit consumer advocacy group working to broaden healthcare options, create an integrative health system based on wellness, and advance the freedom to make health choices. The group promotes the fundamental policies needed to improve health choices and information in the U.S. and internationally. The group works with grassroots and education organizations and partners in the not-for-profit sector to ensure consumer access to dietary supplements, safe foods, a healthy environment and a wide range of healing therapies. Citizens for Health fosters active citizen leadership and organizes natural health consumers to create political and legislative solutions that support those rights.
##################
CONTACT:
James S. Turner: 202-462-8800
James J. Gormley: 914-701-4511 |